argenx SE (ARGX)
981.33
+3.75
(+0.38%)
USD |
NASDAQ |
Nov 12, 16:00
980.52
-0.81
(-0.08%)
After-Hours: 20:00
argenx Market Cap : 60.73B for Nov. 12, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 12, 2026 | 60.73B |
| November 11, 2026 | 60.50B |
| November 10, 2026 | 60.12B |
| November 09, 2026 | 59.55B |
| November 06, 2026 | 57.38B |
| November 05, 2026 | 55.37B |
| November 04, 2026 | 57.64B |
| November 03, 2026 | 55.76B |
| November 02, 2026 | 54.15B |
| October 30, 2026 | 55.25B |
| October 29, 2026 | 55.56B |
| October 28, 2026 | 55.19B |
| October 27, 2026 | 54.61B |
| October 26, 2026 | 53.80B |
| October 23, 2026 | 54.07B |
| October 22, 2026 | 54.19B |
| October 21, 2026 | 55.08B |
| October 20, 2026 | 53.82B |
| October 19, 2026 | 51.09B |
| October 16, 2026 | 50.69B |
| October 15, 2026 | 52.37B |
| October 14, 2026 | 50.64B |
| October 13, 2026 | 49.67B |
| October 12, 2026 | 50.27B |
| October 09, 2026 | 51.06B |
| Date | Value |
|---|---|
| October 08, 2026 | 50.66B |
| October 07, 2026 | 57.45B |
| October 06, 2026 | 57.58B |
| October 05, 2026 | 56.49B |
| October 02, 2026 | 56.88B |
| October 01, 2026 | 57.92B |
| September 30, 2026 | 59.34B |
| September 29, 2026 | 60.07B |
| September 28, 2026 | 60.17B |
| September 25, 2026 | 59.38B |
| September 24, 2026 | 59.55B |
| September 23, 2026 | 58.53B |
| September 22, 2026 | 59.64B |
| September 21, 2026 | 61.15B |
| September 18, 2026 | 61.28B |
| September 17, 2026 | 61.62B |
| September 16, 2026 | 60.94B |
| September 15, 2026 | 60.63B |
| September 14, 2026 | 61.30B |
| September 11, 2026 | 60.92B |
| September 10, 2026 | 60.90B |
| September 09, 2026 | 62.03B |
| September 08, 2026 | 62.32B |
| September 04, 2026 | 63.93B |
| September 03, 2026 | 65.19B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Autolus Therapeutics Plc | 316.94M |
| Cellectis SA | 133.93M |
| Halozyme Therapeutics, Inc. | 11.47B |
| DBV Technologies SA | 718.27M |
| Akari Therapeutics Plc | 11.40M |
Market Cap Related Metrics
| PE Ratio | 37.40 |
| PS Ratio | 12.27 |
| Price to Free Cash Flow | 58.82 |
| Price | 981.33 |
| Earnings Yield | 2.67% |
| Operating PE Ratio | 42.57 |
| Normalized PE Ratio | 37.40 |